ATE132034T1 - Künstliche virushüllen - Google Patents

Künstliche virushüllen

Info

Publication number
ATE132034T1
ATE132034T1 AT91919952T AT91919952T ATE132034T1 AT E132034 T1 ATE132034 T1 AT E132034T1 AT 91919952 T AT91919952 T AT 91919952T AT 91919952 T AT91919952 T AT 91919952T AT E132034 T1 ATE132034 T1 AT E132034T1
Authority
AT
Austria
Prior art keywords
viral envelopes
artificial virus
production
artificial
cases
Prior art date
Application number
AT91919952T
Other languages
English (en)
Inventor
Hans Schreier
Ramesh Chander
Arlene A Stecenko
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of ATE132034T1 publication Critical patent/ATE132034T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Prostheses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT91919952T 1990-10-19 1991-10-17 Künstliche virushüllen ATE132034T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60064190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
ATE132034T1 true ATE132034T1 (de) 1996-01-15

Family

ID=24404456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919952T ATE132034T1 (de) 1990-10-19 1991-10-17 Künstliche virushüllen

Country Status (8)

Country Link
EP (1) EP0555333B1 (de)
JP (1) JP3414395B2 (de)
AT (1) ATE132034T1 (de)
DE (1) DE69115924T2 (de)
DK (1) DK0555333T3 (de)
ES (1) ES2081502T3 (de)
GR (1) GR3018918T3 (de)
WO (1) WO1992006677A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369491C (en) 2000-02-02 2008-09-02 Yasufumi Kaneda Virus envelope vector for gene transfer
WO2002029410A2 (en) 2000-10-06 2002-04-11 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
EP1447080A1 (de) * 2003-02-13 2004-08-18 Bestewil Holding B.V. Methode zur Herstellung von Virosomen-artigen Partikeln

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
DE3068743D1 (en) * 1980-01-16 1984-08-30 Weder Hans G Process and dialysis-installation for the preparation of bilayer-vesicles and their use
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
LU86736A1 (fr) * 1987-01-15 1988-08-23 Univ Bruxelles Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
EP0555333A1 (de) 1993-08-18
DE69115924T2 (de) 1996-05-23
JP3414395B2 (ja) 2003-06-09
ES2081502T3 (es) 1996-03-16
DK0555333T3 (da) 1996-04-29
JPH06502412A (ja) 1994-03-17
EP0555333B1 (de) 1995-12-27
WO1992006677A1 (en) 1992-04-30
GR3018918T3 (en) 1996-05-31
DE69115924D1 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
ATE78492T1 (de) Kovalentlich modifizierte neutrale bakterielle polysaccharide, stabile kovalente konjugate zwischen diesen polysacchariden und immunogenischen proteinen und verfahren zur herstellung dieser polysaccharide und konjugate.
SE8101266L (sv) Arkmaterial for kardiovaskulera och andra protesimplantat
ATE62255T1 (de) Kovalent modifizierte bakterielle polysaccharide, stabile kovalente konjugate von diesen polysacchariden und immunogenischen proteinen mit zweiwertigen bruecken und verfahren zur herstellung von solchen polysacchariden und konjugaten und zur befestigung der kovalenz.
FI925590A7 (fi) Spesifisten immunogeenien ekspressio virusantigeeneja käyttäen
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
FI892312A0 (fi) Expression av hepatitis b, s och pres2 proteiner i metylotropiska jaester.
ATE20250T1 (de) Herstellung von hepatitis-a-virus mit hohem titer.
DK0509008T3 (da) Biomasse til produktion af virus/virusantigener
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
DE69115924D1 (de) Künstliche virushüllen
DE3382072D1 (de) Herstellung von herpes-simplex-virusproteinen.
DE68924155D1 (de) Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
ITRM920350A0 (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
SE8100614L (sv) Humant relaxin och sett for framstellning derav
ES2028444T3 (es) Procedimiento para la preparacion de hidroxialquil-1 nitro-5 imidazoles.
DE69011856D1 (de) Herstellung von hefeextrakt.
DE69109910D1 (de) Herstellung von Ethyl-tert.alkyläthern.
DE3587351D1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
DK447587A (da) Oxolabdaner, deres fremstilling og anvendelse
NL300073I1 (nl) Vaccin.
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
DE3865694D1 (de) Gegen "cucumber mosaic virus"-infektion resistente pflanzen.
IT9019153A0 (it) Valvola cardiaca artificiale, con elevatissimo grado di sicurezza

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee